{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2007-D-0369\" and posted_year = 2021 sorted by posted_date descending", "rows": [["FDA-2007-D-0369-0585", "FDA", "FDA-2007-D-0369", "Draft Guidance on Alprazolam; Revised Guidance; PSG_021726", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:34Z", null, 1, 0, "0900006484e387f6"], ["FDA-2007-D-0369-0586", "FDA", "FDA-2007-D-0369", "Draft Guidance on Colesevelam Hydrochloride; Revised Guidance; PSG_021176", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:34Z", null, 1, 0, "0900006484e387f8"], ["FDA-2007-D-0369-0572", "FDA", "FDA-2007-D-0369", "Draft Guidance on Leuprolide Acetate; Revised Guidance; PSG_021088", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:32Z", null, 1, 0, "0900006484e387dc"], ["FDA-2007-D-0369-0613", "FDA", "FDA-2007-D-0369", "Draft Guidance on Lactitol; New Guidance; PSG_211281", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:38Z", null, 1, 0, "0900006484e38839"], ["FDA-2007-D-0369-0606", "FDA", "FDA-2007-D-0369", "Draft Guidance on Metoclopramide Hydrochloride; Revised Guidance; PSG_022246", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:37Z", null, 1, 0, "0900006484e3882b"], ["FDA-2007-D-0369-0603", "FDA", "FDA-2007-D-0369", "Draft Guidance on Desloratadine; Revised Guidance; PSG_021312", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:37Z", null, 1, 0, "0900006484e38825"], ["FDA-2007-D-0369-0615", "FDA", "FDA-2007-D-0369", "Draft Guidance on Cenobamate; New Guidance; PSG_212839", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:39Z", null, 1, 0, "0900006484e3883d"], ["FDA-2007-D-0369-0591", "FDA", "FDA-2007-D-0369", "Draft Guidance on Riluzole; New Guidance; PSG_209080", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:35Z", null, 1, 0, "0900006484e38802"], ["FDA-2007-D-0369-0578", "FDA", "FDA-2007-D-0369", "Draft Guidance on Dicyclomine Hydrochloride; New Guidance; PSG_007409-Tab", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:33Z", null, 1, 0, "0900006484e387e8"], ["FDA-2007-D-0369-0580", "FDA", "FDA-2007-D-0369", "Draft Guidance on Ondansetron; Revised Guidance; PSG_020781", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:33Z", null, 1, 0, "0900006484e387ec"], ["FDA-2007-D-0369-0588", "FDA", "FDA-2007-D-0369", "Draft Guidance on Loratadine; Revised Guidance; PSG_020704", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:35Z", null, 1, 0, "0900006484e387fc"], ["FDA-2007-D-0369-0589", "FDA", "FDA-2007-D-0369", "Draft Guidance on Minocycline Hydrochloride; New Guidance; PSG_209269", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:35Z", null, 1, 0, "0900006484e387fe"], ["FDA-2007-D-0369-0569", "FDA", "FDA-2007-D-0369", "Draft Guidance on Artesunate; New Guidance; PSG_213036", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:32Z", null, 1, 0, "0900006484e37440"], ["FDA-2007-D-0369-0610", "FDA", "FDA-2007-D-0369", "Draft Guidance onColesevelam Hydrochloride; Revised Guidance; PSG_022362", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:38Z", null, 1, 0, "0900006484e38833"], ["FDA-2007-D-0369-0608", "FDA", "FDA-2007-D-0369", "Draft Guidance on Minocycline Hydrochloride; New Guidance; PSG_213690", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:38Z", null, 1, 0, "0900006484e3882f"], ["FDA-2007-D-0369-0614", "FDA", "FDA-2007-D-0369", "Draft Guidance on Pemigatinib; New Guidance; PSG_213736", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:39Z", null, 1, 0, "0900006484e3883b"], ["FDA-2007-D-0369-0594", "FDA", "FDA-2007-D-0369", "Draft Guidance on Bempedoic Acid; New Guidance; PSG_211616", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:35Z", null, 1, 0, "0900006484e38808"], ["FDA-2007-D-0369-0600", "FDA", "FDA-2007-D-0369", "Draft Guidance on Cetirizine Hydrochloride; Revised Guidance; PSG_022578", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:36Z", null, 1, 0, "0900006484e3881f"], ["FDA-2007-D-0369-0590", "FDA", "FDA-2007-D-0369", "Draft Guidance on Olanzapine; Revised Guidance; PSG_021086", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:35Z", null, 1, 0, "0900006484e38800"], ["FDA-2007-D-0369-0597", "FDA", "FDA-2007-D-0369", "Draft Guidance on Tenapanor Hydrochloride; New Guidance; PSG_211801", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:36Z", null, 1, 0, "0900006484e38818"], ["FDA-2007-D-0369-0609", "FDA", "FDA-2007-D-0369", "Draft Guidance on Carbidopa; Levodopa; Revised Guidance; PSG_076699", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:38Z", null, 1, 0, "0900006484e38831"], ["FDA-2007-D-0369-0593", "FDA", "FDA-2007-D-0369", "Draft Guidance on Lansoprazole; Revised Guidance; PSG_021428", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:35Z", null, 1, 0, "0900006484e38806"], ["FDA-2007-D-0369-0612", "FDA", "FDA-2007-D-0369", "Draft Guidance on Opicapone; New Guidance;  PSG_212489", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:38Z", null, 1, 0, "0900006484e38837"], ["FDA-2007-D-0369-0567", "FDA", "FDA-2007-D-0369", "Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability", "Notice", "Notice of Availability", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", "2022-01-11T04:59:59Z", "2021-12-31T02:00:32Z", "2021-24431", 0, 0, "0900006484e37a93"], ["FDA-2007-D-0369-0575", "FDA", "FDA-2007-D-0369", "Draft Guidance on Leuprolide Acetate; Norethindrone Acetate; Revised Guidance; PSG_203696", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:32Z", null, 1, 0, "0900006484e387e2"], ["FDA-2007-D-0369-0568", "FDA", "FDA-2007-D-0369", "Draft Guidance on Beclomethasone Dipropionate Monohydrate; New Guidance; PSG_019389", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:31Z", null, 1, 0, "0900006484e3743e"], ["FDA-2007-D-0369-0574", "FDA", "FDA-2007-D-0369", "Draft Guidance on Remimazolam Besylate; New Guidance; PSG_212295", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:32Z", null, 1, 0, "0900006484e387e0"], ["FDA-2007-D-0369-0582", "FDA", "FDA-2007-D-0369", "Draft Guidance on Sodium Iodide I-131; New Guidance; PSG_016517", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:34Z", null, 1, 0, "0900006484e387f0"], ["FDA-2007-D-0369-0587", "FDA", "FDA-2007-D-0369", "Draft Guidance on Tucatinib; New Guidance; PSG_213411", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:34Z", null, 1, 0, "0900006484e387fa"], ["FDA-2007-D-0369-0571", "FDA", "FDA-2007-D-0369", "Draft Guidance on Triamcinolone Acetonide; Revised Guidance; PSG_012041", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:32Z", null, 1, 0, "0900006484e387da"], ["FDA-2007-D-0369-0573", "FDA", "FDA-2007-D-0369", "Draft Guidance on Ciclesonide; New Guidance; PSG_022004", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:32Z", null, 1, 0, "0900006484e387de"], ["FDA-2007-D-0369-0576", "FDA", "FDA-2007-D-0369", "Draft Guidance on Donepezil Hydrochloride; Revised Guidance; PSG_021720", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:33Z", null, 1, 0, "0900006484e387e4"], ["FDA-2007-D-0369-0581", "FDA", "FDA-2007-D-0369", "Draft Guidance on Minocycline Hydrochloride; New Guidance; PSG_212379", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:33Z", null, 1, 0, "0900006484e387ee"], ["FDA-2007-D-0369-0583", "FDA", "FDA-2007-D-0369", "Draft Guidance on Risperidone; Revised Guidance; PSG_021444", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:34Z", null, 1, 0, "0900006484e387f2"], ["FDA-2007-D-0369-0595", "FDA", "FDA-2007-D-0369", "Draft Guidance on Glucagon; New Guidance; PSG_212097", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:36Z", null, 1, 0, "0900006484e38814"], ["FDA-2007-D-0369-0598", "FDA", "FDA-2007-D-0369", "Draft Guidance on Potassium Phosphate, Dibasic; Potassium Phosphate, Monobasic; New Guidance; PSG_212832", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:36Z", null, 1, 0, "0900006484e3881a"], ["FDA-2007-D-0369-0607", "FDA", "FDA-2007-D-0369", "Draft Guidance on Bempedoic Acid; Ezetimibe; New Guidance; PSG_211617", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:37Z", null, 1, 0, "0900006484e3882d"], ["FDA-2007-D-0369-0599", "FDA", "FDA-2007-D-0369", "Draft Guidance on Diclofenac Potassium; New Guidance; PSG_020142", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:36Z", null, 1, 0, "0900006484e3881c"], ["FDA-2007-D-0369-0601", "FDA", "FDA-2007-D-0369", "Draft Guidance on Colesevelam Hydrochloride; New Guidance; PSG_210895", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:37Z", null, 1, 0, "0900006484e38821"], ["FDA-2007-D-0369-0602", "FDA", "FDA-2007-D-0369", "Draft Guidance on Clascoterone; New Guidance; PSG_213433", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:37Z", null, 1, 0, "0900006484e38823"], ["FDA-2007-D-0369-0577", "FDA", "FDA-2007-D-0369", "Draft Guidance on Mirtazapine; Revised Guidance; PSG_021208", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:33Z", null, 1, 0, "0900006484e387e6"], ["FDA-2007-D-0369-0584", "FDA", "FDA-2007-D-0369", "Draft Guidance on Potassium Phosphate, Dibasic; Potassium Phosphate, Monobasic; New Guidance; PSG_212121", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:34Z", null, 1, 0, "0900006484e387f4"], ["FDA-2007-D-0369-0596", "FDA", "FDA-2007-D-0369", "Draft Guidance on Lemborexant; New Guidance; PSG_212028", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:36Z", null, 1, 0, "0900006484e38816"], ["FDA-2007-D-0369-0604", "FDA", "FDA-2007-D-0369", "Draft Guidance on Draft Guidance on Lurbinectedin; New Guidance; PSG_213702", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:37Z", null, 1, 0, "0900006484e38827"], ["FDA-2007-D-0369-0605", "FDA", "FDA-2007-D-0369", "Draft Guidance on Rimegepant Sulfate; New Guidance; PSG_212728", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:37Z", null, 1, 0, "0900006484e38829"], ["FDA-2007-D-0369-0611", "FDA", "FDA-2007-D-0369", "Draft Guidance on Zolmitriptan; Revised Guidance; PSG_021231", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:38Z", null, 1, 0, "0900006484e38835"], ["FDA-2007-D-0369-0592", "FDA", "FDA-2007-D-0369", "Draft Guidance on Rizatriptan Benzoate; Revised Guidance; PSG_020865", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:35Z", null, 1, 0, "0900006484e38804"], ["FDA-2007-D-0369-0570", "FDA", "FDA-2007-D-0369", "Draft Guidance on Aripiprazole; Revised Guidance; PSG_021729", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:32Z", null, 1, 0, "0900006484e387d8"], ["FDA-2007-D-0369-0579", "FDA", "FDA-2007-D-0369", "Draft Guidance on Methylphenidate; Revised Guidance; PSG_205489", "Other", "Guidance", "2021-11-09T05:00:00Z", 2021, 11, "2021-11-09T05:00:00Z", null, "2024-11-07T00:33:33Z", null, 1, 0, "0900006484e387ea"], ["FDA-2007-D-0369-0561", "FDA", "FDA-2007-D-0369", "Product-Specific Guidances for Ferric Oxyhydroxide; Revised Draft\nGuidances for Industry; Availability", "Notice", "Notice of Availability", "2021-09-17T04:00:00Z", 2021, 9, "2021-09-17T04:00:00Z", "2021-11-17T04:59:59Z", "2021-11-18T02:00:11Z", "2021-20064", 0, 0, "0900006484d8c141"], ["FDA-2007-D-0369-0560", "FDA", "FDA-2007-D-0369", "Product-Specific Guidances; Draft and \nRevised Draft Guidances for Industry; \nAvailability", "Notice", "Notice of Availability", "2021-08-23T04:00:00Z", 2021, 8, "2021-08-23T04:00:00Z", "2021-10-23T03:59:59Z", "2021-10-21T01:00:31Z", "2021-18072", 0, 0, "0900006484c9bafb"], ["FDA-2007-D-0369-0558", "FDA", "FDA-2007-D-0369", "Product-Specific Guidance for Olodaterol Hydrochloride; Tiotropium Bromide; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2021-07-28T04:00:00Z", 2021, 7, "2021-07-28T04:00:00Z", "2021-09-28T03:59:59Z", "2021-09-25T01:00:52Z", "2021-16046", 0, 0, "0900006484c14747"], ["FDA-2007-D-0369-0554", "FDA", "FDA-2007-D-0369", "Product-Specific Guidance for Cilastatin Sodium; Imipenem; Relebactam; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2021-07-19T04:00:00Z", 2021, 7, "2021-07-19T04:00:00Z", "2021-09-18T03:59:59Z", "2021-08-05T20:00:36Z", "2021-15170", 0, 0, "0900006484c01943"], ["FDA-2007-D-0369-0555", "FDA", "FDA-2007-D-0369", "Draft Guidance on Cilastatin Sodium; Imipenem; Relebactam\nJuly 2021", "Other", "Guidance", "2021-07-19T04:00:00Z", 2021, 7, "2021-07-19T04:00:00Z", null, "2021-07-30T18:56:04Z", null, 0, 0, "0900006484c01d82"], ["FDA-2007-D-0369-0550", "FDA", "FDA-2007-D-0369", "Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability", "Notice", "Notice of Availability", "2021-05-20T04:00:00Z", 2021, 5, "2021-05-20T04:00:00Z", "2021-07-20T03:59:59Z", "2021-08-11T01:00:51Z", "2021-10589", 0, 0, "0900006484b23761"], ["FDA-2007-D-0369-0548", "FDA", "FDA-2007-D-0369", "Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability", "Notice", "Notice of Availability", "2021-03-29T04:00:00Z", 2021, 3, "2021-03-29T04:00:00Z", "2021-05-25T03:59:59Z", "2021-03-29T12:28:38Z", "2021\u201306202", 0, 0, "0900006484a84f91"], ["FDA-2007-D-0369-0547", "FDA", "FDA-2007-D-0369", "Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability", "Notice", "Notice of Availability", "2021-03-25T04:00:00Z", 2021, 3, "2021-03-25T04:00:00Z", "2021-05-25T03:59:59Z", "2021-05-25T01:00:43Z", "2021-06202", 0, 0, "0900006484a7a413"]], "truncated": false, "filtered_table_rows_count": 57, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-2007-D-0369", "p1": "2021"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021", "results": [{"value": "FDA", "label": "FDA", "count": 57, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021", "results": [{"value": "Other", "label": "Other", "count": 49, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021&document_type=Other", "selected": false}, {"value": "Notice", "label": "Notice", "count": 8, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021", "results": [{"value": 2021, "label": 2021, "count": 57, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021&_facet=comment_end_date"}, {"name": "last_modified", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021&_facet=last_modified"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2021&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 995.7904890179634, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}